TocilizumabV1, Main, Merge, indexHead, AutAff.i

Author's uniq id: Strand V
Total number of names:
Total number of records with affiliations: 105

V Strand

NONE (BIBLIO)

000014
000044
000159
000344
000367
000402
000661
000663
000725
000795
000868
000872
000A00
000A94
000A96
000B30
000B56
000B77
000B79
000B84
000C93
000C97
000D08
000D22
000D25
000D41
000D43
000D49
000D68
000E16
000E20
000E78
000F32
001034
001106
001262
001408
001461
001463
001516
001588
001678
001702
001757
001A97
001C37
002021
002355
002395
002474
002484
002493
002669
002758
002777
002793
003A01
003A17
003C91
004163

V. Strand

Royaume-Uni Rebecca MacDonald Centre for Arthritis and Autoimmune Disorders, Mt Sinai Hospital, Toronto, ON, Canada; MCRC, Univ of Texas, Dallas, TX, USA; Div of Rheum, Univ of Vienna, Vienna, Austria; Div of Immunol/Rheumatol, Stanford Univ, Palo Alto, CA, USA; Div of Rheum, Univ Hospital Maastricht, Maastricht, Netherlands; Immuno-Rheumatologie, Hospital Lapeyronie, Montpellier, France; Seattle Rheum Associates, Seattle, WA, USA; Biostatistics, UCB, Slough, UK; UCB, Smyrna, GA; Dept of Rheum, Leiden Univ Medical Center, Leiden, Netherlands; University of Leeds, Leeds Leeds	003D51
États-Unis Division of Immunology and Rheumatology, Stanford University, Palo Alto, California Californie	003608
États-Unis Californie Stanford University School of Medicine	003090
	003074
Alto	003074
NONE (BIBLIO)	000099 000397 000539 000651 000746 000752 000898 000B51 000C32 000D27 000D31 000D75 000E11 000E99 000F28 000F73 001023 001408 001446 001919 001F89
Alto	003074

Vibeke Strand

Stanford University School of Medicine, Palo Alto, USA. États-Unis Stanford University School of Medicine, Palo Alto Palo Alto	003A11
0000000419368956grid.168010.eImmunology/Rheumatology,Stanford University,Stanford, USA États-Unis Stanford	001711
Stanford University School of Medicine,Palo Alto, California,USA États-Unis # see nlm:aff country strict	001678
Stanford University,Palo Alto, California,USA États-Unis # see nlm:aff country strict	002758
Department of Immunology and Rheumatology,Stanford University,Palo Alto,California,USA États-Unis # see nlm:aff country strict	000868
Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028, USA. vstrand@stanford.edu. États-Unis Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028 94028	001E91
Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305, USA. vstrand@stanford.edu États-Unis Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305 California 94305	003C94
États-Unis Dept Rheumatology, Univ Hospital KU Leuven, Leuven, Belgium; Div Immunol/Rheumatol, Stanford Univ, Palo Alto, CA, USA; Rebecca MacDonald Ctr for Arthritis and Autoimmune Diseases, Mt Sinai Hospital, Toronto, ON, Canada; Outcomes and Access Immunology, UCB, Brussels, Belgium; Dept Rheumatology, UCLA, Los Angeles, CA, USA; Div Rheumatology, Univ of Vienna, Vienna, Austria; Div Rheum, UCSD, San Diego, CA Californie	003D51
États-Unis Stanford University School of Medicine, Palo Alto, California Californie	003A64
Division of Immunology, Stanford UniversityPortola Valley, CAUSA1 aut. États-Unis Californie	003869
0000000419368956grid.168010.eStanford University,Palo Alto, CA USA États-Unis Californie Palo Alto	001262
grid.168010.e0000000419368956Stanford University,Palo Alto, CA USA États-Unis Californie Palo Alto	000159
Division of Immunology and Rheumatology, Stanford University Medical School, Palo Alto, California, USA. États-Unis Division of Immunology and Rheumatology, Stanford University Medical School, Palo Alto, California Californie	001345
Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA. États-Unis Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California Californie	001786
Division of Immunology, Stanford University School of Medicine, Palo Alto, California, USA. États-Unis Division of Immunology, Stanford University School of Medicine, Palo Alto, California Californie	004255
Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. vstrand@stanford.edu États-Unis Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028 Californie	003527
Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USA. États-Unis Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA Californie	000C44
c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA , USA. États-Unis c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA Californie	001858

<g><k>Strand V</k>
<l><g><k>V Strand</k>
<l><g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000014</i>
<i>000044</i>
<i>000159</i>
<i>000344</i>
<i>000367</i>
<i>000402</i>
<i>000661</i>
<i>000663</i>
<i>000725</i>
<i>000795</i>
<i>000868</i>
<i>000872</i>
<i>000A00</i>
<i>000A94</i>
<i>000A96</i>
<i>000B30</i>
<i>000B56</i>
<i>000B77</i>
<i>000B79</i>
<i>000B84</i>
<i>000C93</i>
<i>000C97</i>
<i>000D08</i>
<i>000D22</i>
<i>000D25</i>
<i>000D41</i>
<i>000D43</i>
<i>000D49</i>
<i>000D68</i>
<i>000E16</i>
<i>000E20</i>
<i>000E78</i>
<i>000F32</i>
<i>001034</i>
<i>001106</i>
<i>001262</i>
<i>001408</i>
<i>001461</i>
<i>001463</i>
<i>001516</i>
<i>001588</i>
<i>001678</i>
<i>001702</i>
<i>001757</i>
<i>001A97</i>
<i>001C37</i>
<i>002021</i>
<i>002355</i>
<i>002395</i>
<i>002474</i>
<i>002484</i>
<i>002493</i>
<i>002669</i>
<i>002758</i>
<i>002777</i>
<i>002793</i>
<i>003A01</i>
<i>003A17</i>
<i>003C91</i>
<i>004163</i>
</l>
<n>60</n>
<t>60</t>
</g>
</l>
<n>1</n>
<t>60</t>
</g>
<g><k>V. Strand</k>
<l><g><k><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Rebecca MacDonald Centre for Arthritis and Autoimmune Disorders, Mt Sinai Hospital, Toronto, ON, Canada; MCRC, Univ of Texas, Dallas, TX, USA; Div of Rheum, Univ of Vienna, Vienna, Austria; Div of Immunol/Rheumatol, Stanford Univ, Palo Alto, CA, USA; Div of Rheum, Univ Hospital Maastricht, Maastricht, Netherlands; Immuno-Rheumatologie, Hospital Lapeyronie, Montpellier, France; Seattle Rheum Associates, Seattle, WA, USA; Biostatistics, UCB, Slough, UK; UCB, Smyrna, GA; Dept of Rheum, Leiden Univ Medical Center, Leiden, Netherlands; University of Leeds, Leeds</wicri:regionArea>
<wicri:noRegion>Leeds</wicri:noRegion>
</affiliation>
</k>
<l><i>003D51</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology and Rheumatology, Stanford University, Palo Alto, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>003608</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Stanford University School of Medicine</wicri:cityArea>
</affiliation>
</k>
<l><i>003090</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation></affiliation>
</k>
<l><i>003074</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation><wicri:noCountry code="subField">Alto</wicri:noCountry>
</affiliation>
</k>
<l><i>003074</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation>NONE (BIBLIO)</affiliation>
</k>
<l><i>000099</i>
<i>000397</i>
<i>000539</i>
<i>000651</i>
<i>000746</i>
<i>000752</i>
<i>000898</i>
<i>000B51</i>
<i>000C32</i>
<i>000D27</i>
<i>000D31</i>
<i>000D75</i>
<i>000E11</i>
<i>000E99</i>
<i>000F28</i>
<i>000F73</i>
<i>001023</i>
<i>001408</i>
<i>001446</i>
<i>001919</i>
<i>001F89</i>
</l>
<n>21</n>
<t>21</t>
</g>
<g><k><wicri:noCountry code="subField">Alto</wicri:noCountry>
</k>
<l><i>003074</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>7</n>
<t>27</t>
</g>
<g><k>Vibeke Strand</k>
<l><g><k><affiliation wicri:level="1"><nlm:aff id="A31"> Stanford University School of Medicine, Palo Alto, USA.</nlm:aff>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea> Stanford University School of Medicine, Palo Alto</wicri:regionArea>
<wicri:noRegion>Palo Alto</wicri:noRegion>
</affiliation>
</k>
<l><i>003A11</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:aff id="Aff380"><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id>
<institution-id institution-id-type="GRID">grid.168010.e</institution-id>
<institution>Immunology/Rheumatology,</institution>
<institution>Stanford University,</institution>
</institution-wrap>
Stanford, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Stanford</wicri:regionArea>
</affiliation>
</k>
<l><i>001711</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:aff id="af1"><institution>Stanford University School of Medicine</institution>
,<addr-line>Palo Alto, California</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</k>
<l><i>001678</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:aff id="af5"><institution>Stanford University</institution>
,<addr-line>Palo Alto, California</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</k>
<l><i>002758</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:aff id="aff2"><institution content-type="department">Department of Immunology and Rheumatology</institution>
,<institution>Stanford University</institution>
,<addr-line content-type="city">Palo Alto</addr-line>
,<addr-line content-type="state">California</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</k>
<l><i>000868</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:affiliation>Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028, USA. vstrand@stanford.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Biopharmaceutical Consultant, 306 Ramona Road, Portola Valley, CA, 94028</wicri:regionArea>
<wicri:noRegion>94028</wicri:noRegion>
</affiliation>
</k>
<l><i>001E91</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="1"><nlm:affiliation>Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305, USA. vstrand@stanford.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California 94305</wicri:regionArea>
<wicri:noRegion>California 94305</wicri:noRegion>
</affiliation>
</k>
<l><i>003C94</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dept Rheumatology, Univ Hospital KU Leuven, Leuven, Belgium; Div Immunol/Rheumatol, Stanford Univ, Palo Alto, CA, USA; Rebecca MacDonald Ctr for Arthritis and Autoimmune Diseases, Mt Sinai Hospital, Toronto, ON, Canada; Outcomes and Access Immunology, UCB, Brussels, Belgium; Dept Rheumatology, UCLA, Los Angeles, CA, USA; Div Rheumatology, Univ of Vienna, Vienna, Austria; Div Rheum, UCSD, San Diego, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>003D51</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Stanford University School of Medicine, Palo Alto, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>003A64</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Division of Immunology, Stanford University</s1>
<s2>Portola Valley, CA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>003869</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000000419368956</institution-id>
<institution-id institution-id-type="GRID">grid.168010.e</institution-id>
<institution>Stanford University,</institution>
</institution-wrap>
Palo Alto, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Palo Alto</wicri:cityArea>
</affiliation>
</k>
<l><i>001262</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.168010.e</institution-id>
<institution-id institution-id-type="ISNI">0000000419368956</institution-id>
<institution>Stanford University,</institution>
</institution-wrap>
Palo Alto, CA USA</nlm:aff>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Palo Alto</wicri:cityArea>
</affiliation>
</k>
<l><i>000159</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>Division of Immunology and Rheumatology, Stanford University Medical School, Palo Alto, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology and Rheumatology, Stanford University Medical School, Palo Alto, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>001345</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>001786</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>Division of Immunology, Stanford University School of Medicine, Palo Alto, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology, Stanford University School of Medicine, Palo Alto, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>004255</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028, USA. vstrand@stanford.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology, Stanford University, 306 Ramona Road, Portola Valley, CA 94028</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>003527</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>000C44</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g><k><affiliation wicri:level="2"><nlm:affiliation>c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>c Division of Immunology/Rheumatology , Stanford University , Palo Alto , CA </wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</k>
<l><i>001858</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>18</n>
<t>18</t>
</g>
</l>
<n>3</n>
<t>105</t>
</g>

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab